Background A growing body of evidence supports the role of type 2 diabetes as an individual-level risk factor for tuberculosis (TB), though evidence from developing countries with the highest TB burdens is lacking. In developing countries, TB is most common among the poor, in whom diabetes may be less common. We assessed the relationship between individual-level risk, social determinants and population health in these settings.
Introduction
When chronic non-communicable diseases proliferate faster than infectious diseases recede, previously uncommon disease interactions can take on population health significance. Recent systematic reviews 1,2 suggest that type 2 diabetes mellitus (T2DM) increases individual risk of Mycobacterium tuberculosis (TB) disease. Country-level analyses suggest that TB prevalence is mediated by both social determinants and public health strategies. 3, 4 Yet, strikingly little work has been done to assess the relationship of TB and diabetes at the individual level in countries where TB prevalence is highest and diabetes prevalence is rising most rapidly. Given increases in diabetes and the persistence of TB in these areas, the relationship of individual risks, social determinants and population health impacts due to interactions between diabetes and TB should be assessed.
Classical descriptions of epidemiologic transition involve the replacement of infectious diseases of deprivation with non-communicable diseases of affluence, 5 though currently many countries face growing dual disease burdens. 6 Diabetes prevalence continues to rise rapidly in developing countries, driven by changes in diet and lifestyle. 7 Though historically having fewer diabetic individuals than their share of the world's population would imply, by 2025, India, China, Indonesia, Pakistan and Brazil alone are projected to carry nearly half the world's diabetes burden. 7 In many countries, TB epidemics continue, fueled by drug resistance, 8 HIV/AIDS 9,10 and social inequalities. 4 Analyses that inform both TB and diabetes policies must estimate the individual-level relationship between the two conditions and translate it into projections of future population burden, accounting for mediating effects of social determinants and prevailing health policies. Though few such studies exist, it is suggested that the impact of a diabetes/TB interaction may play a substantial role in fueling the ongoing TB epidemic in India. 11 Given existing data limitations, such studies have necessarily depended on the assumption that the strength of association between diabetes and TB risk is the same as that estimated almost exclusively from non-populationrepresentative studies from higher income countries.
In order to appreciate the global population health significance of rising diabetes prevalence in the presence of persistent TB epidemics in settings where current TB burdens are high, we evaluated the relationship of diabetes and TB at both individual and country levels using population-representative data from largely lower income countries.
Methods
An individual-level cross-sectional analysis examined the association between symptoms of TB and self-reported diagnosed diabetes conditioning on known TB risk factors across individuals from 46 countries. This analysis was repeated for countries grouped by geographic region to assess how the relationship as well as mediating influences of social determinants varied across regions. A country-level analysis examined the association between diabetes and TB prevalence across 163 countries. Its goals were to assess the impact of longitudinal increases in diabetes prevalence on changes in TB prevalence and incidence; and identify countries potentially 'at risk' for TB/diabetes interactions because of the high prevalence of both.
Individual-level analysis
Data were derived from individual responses to the World Health Organization's (WHO) 2002-03 World Health Survey (WHS). 12, 13 This analysis included individuals in countries that had sampling weights available and used the WHS long-form questionnaire, providing self-reported diabetes diagnosis and symptoms of TB. The main analysis employed data on individual adults (n ¼ 124 545; representing approximately 400 million people) from all 46 countries for which these data are available ( Table 1) .
The main outcome was the presence of symptoms of active TB disease. Microbiological confirmation was not possible as the WHS did not include mycobacterial culture or sputum smear microscopy. We classified active TB as an affirmative response to two questions: 'Over the last 12 months, have you had blood in your phlegm or have you coughed blood?' and 'Over the last 12 months, have you experienced cough lasting 3 weeks or longer?'. It has previously been shown that such questions have sensitivities between 65 and 70% and specificities between 55 and 75% for TB with other respiratory conditions also associated with an affirmative answer. [14] [15] [16] The main predictor was the presence of T2DM. Because the WHS did not test fasting-plasma glucose, we classified individuals as having diabetes if they responded affirmatively to the question: 'Have you ever been diagnosed with diabetes (high blood sugar)?' It has previously been shown that the sensitivities and specificities of such questions are $65-85% and 95-99%, respectively, compared with biochemical markers or clinical records, with overall Kappas of 0.70-0.85. [17] [18] [19] [20] [21] [22] Though the cross-sectional nature of the analysis precluded statements about time ordering and causality, we interpreted a positive association between our outcome and predictor as evidence consistent with prior longitudinal studies showing that diabetes increased subsequent risk of developing active TB. 1, [23] [24] [25] [26] The model included covariates that have previously been associated with TB: gender, age categorized in 10-year intervals; body mass index (BMI) categorized as 417, 17-20, 20-25, 25-30, 530 ; schooling in years categorized as <1, 1-7, 8-12, 412 ; current daily smoking and the number of years a person has been a daily smoker; drinking at least 1 drink per day in the previous week; urban or rural residence; number of individuals living in the household, number of individuals per room; socio-economic status defined by whether the house had floors made from tile, cement, brick or wood and walls made from cement, brick, stone or wood, whether the house had toilet facilities flushed to a piped sewage system or septic tank, per-capita household total expenditure in the previous month expressed in year 2003 international dollars calculated using purchasing power parity (PPP) 27 and having health insurance. We estimated univariable associations between TB and each covariate as unadjusted odds ratios (ORs). Given the large sample size, we included all covariates in the multivariable models to obtain adjusted ORs. We fit two multivariable models. The first included all covariates except diabetes to assess how ORs for known TB risk factors changed from the crude analyses when they were simultaneously included. The second included all covariates and diabetes to assess the final adjusted relationship of TB and diabetes.
The multivariable analysis was repeated for individuals from subgroups of the countries formed by geographic regions (Africa, Asia, Latin America and Europe). ORs were compared for consistency of relationships across regions.
To explore the effects of relative socio-economic status on the relationship between TB and diabetes, we augmented the multivariable model with indicator variables for an individual's relative expenditure (household expenditure tertile) compared either with other individuals in the same country or with individuals in all countries in the same per-capita gross domestic product (GDP) quintile. We also included interactions between diabetes and the relative expenditure measures. Additionally, we assessed interactions between gender, age, smoking and alcohol consumption and measures of relative expenditure.
To assess potential bias due to non-response, we compared the association between TB and each covariate separately for the sample restricted to individuals who responded for all covariates and for all individuals who provided a response for the particular covariate. We assessed the possibility of misclassification of diabetes and TB due to self-report. Since self-reported diagnosed diabetes may not capture true diabetes status, we confirmed that other covariates had expected relationships with self-reported diabetes (e.g. positive association with higher BMI). Collinearity between variables in the multivariable model was assessed using correlation coefficients, with those highly collinear variables deleted one at a time in an analysis to assess the extent to which collinearity impacted ORs and confidence intervals (CIs).
All individual-level analyses used logistic regressions with individual sampling weights (13), country-fixed 
Country-level analysis
Data included adult population size and diabetes prevalence, 28, 29 WHO estimates of TB prevalence and incidence, 30 and per-capita GDP expressed in year 2005 international dollars using PPP. 31 Included countries had total adult populations of 3.2 billion in 1995 and 3.6 billion in 2003. We examined the relationship between TB prevalence and TB incidence, diabetes prevalence, and per-capita GDP longitudinally between 1990-95 and 2003-04. Longitudinal changes in TB incidence, TB prevalence and diabetes prevalence from 1990-95 to 2003-04 were characterized by logistic regression to quantify the association between increases in diabetes and in TB (prevalence or incidence) conditioning on a country's GDP quintile in 1995. We also identified countries with relatively high TB and diabetes prevalence using a cut-off that also provided sufficient numbers of dual burden countries with WHS data for further individual-level sub-analyses (both values above the 45th percentile across all countries in 2003).
Software
All analyses were undertaken using Stata/SE 10.1 for Windows (StataCorp, USA).
Results

Individual-level analysis
In 46 mainly low-and middle-income countries, individuals reporting a diabetes diagnosis were more likely to have symptoms of TB (coughing blood or blood in sputum, cough lasting 3 weeks or longer) (univariable OR: 2.39; 95% CI: 1.84-3.10; multivariable OR: 1.81; 95% CI: 1.37-2.39). Table 2 describes the characteristics of included individuals from the 46 WHS countries. Of the study population, 1.4% reported coughing blood or blood in their sputum in the past 12 months as well as cough lasting 53 weeks and were classified as having TB, while 3.6% reported being diagnosed with diabetes. The study population included slightly more women than men, and the majority of individuals were <40 years of age. Most individuals were normal weight (BMI 20-25) though 5.5% had a BMI <17%, and 8.7% had a BMI 430. Of individuals, 59.3% reported 58 years of schooling. Nearly 20% were smokers, and 8.4% reported drinking at least 1 drink per day. Over two-thirds lived in homes with good floors and walls, but only half lived in homes with good toilet facilities. Approximately half lived in urban areas. There was substantial variation in household size (5th to 95th percentile: 1-11 people), crowding (5th to 95th percentile: 0.3-5.0 people per room) and monthly per-capita household expenditure (5th to 95th percentile: I$3.0-I$474 per person). Approximately 40% of individuals reported having health insurance.
In univariable analyses ( Including a measure of relative expenditure (per-capita household expenditure tertile), compared either with other individuals of the same country or with to individuals within the same GDP quintile, did not alter the direction or magnitude of our main findings (Appendix Table 1 , available at IJE online). Similarly, when relative expenditure and its interaction with diabetes were included, the direction and magnitude of our main findings did not change. Importantly, no specific pattern of excess TB risk conditional on diabetes at particular relative expenditure levels emerged. Similarly, when we considered interactions between relative expenditure and gender, age, smoking and alcohol consumption, the direction and magnitude of the relationship between TB and diabetes did not change, nor did we observe strong gradients between relative expenditure and any of these other variables.
In multivariable analyses restricted to nine countries with high burdens of both TB and diabetes (Table 5) , the relationship between TB and diabetes strengthened slightly (OR: from 1.81 to 2.00) (Appendix Table 2 , available at IJE online).
Findings were generally robust to sensitivity analyses assessing selection bias, self-report of diabetes and the symptomatic definition of a TB case (Appendix Tables 3, 4 , and 5, available at IJE online). Though some variables, namely those related to socioeconomic status, housing quality and crowding were collinear, findings from the multivariable analysis were largely unaffected by this collinearity.
Country-level analysis Over 10 years, TB was more likely to increase in countries where diabetes prevalence increased (for TB . This is the case despite the fact that higher diabetes prevalence accompanied lower TB prevalence in both the 1990s and 2000s. Countries with higher diabetes prevalence tended to have lower TB prevalence and incidence in both periods (1990-95: Spearman's rho: prevalence À0.53; P < 0.0001 and incidence À0.52; P < 0.0001; 2003-04: r: prevalence À0.62; P < 0.0001 and incidence À0.63; P < 0.0001). There is also a strong GDP gradient: TB prevalence and incidence had a negative association with per-capita GDP (1990-95: rho: prevalence À0.75; P < 0.0001 and incidence À0.72; P < 0.0001; 2003-04: rho: prevalence À0.77; P < 0.0001 and incidence À0.74; P < 0.0001), whereas diabetes prevalence was positively associated with per-capita GDP (1990-95: rho: 0.57; P < 0.0001; 2003-04: rho: 0.64; P < 0.0001). In 2003-04, 29 countries had both higher burdens of diabetes (44.6% prevalence) and TB (40.06% prevalence) ( Table 5 ). These high-TB/high-diabetes burden countries represent 28% of the adult population (approximately 1 billion people) of the 163 countries.
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Discussion
Individuals in lower income countries, where the majority of the world's TB burden is located, were more likely to report symptoms of active TB disease if they also reported a prior diagnosis of T2DM. At the population level, between the 1990s and early 2000s, TB prevalence and incidence were more likely to increase in countries in which diabetes prevalence increased, conditioning on base year, per-capita GDP. Countries of particular concern given their size, substantial TB burdens and large projected increases in diabetes prevalence 7, 30 include Brazil, China, India, Peru and the Russian Federation.
While epidemiologic transitions classically involve shifts from infectious to non-communicable diseases, the lingering presence of both diseases heightens the risk of interaction. With nearly 1 billion individuals currently living in developing countries with substantial burdens of both TB and diabetes and rising trends of diabetes prevalence worldwide, our findings highlight the need for appropriate public health action.
This work contributes to a growing body of evidence on the importance of the TB/diabetes relationship. Notably, it considers population-representative data with large sample sizes from lower income countries, examining the relationship at both the country and individual level. The results confirm TB's relationship with known risk factors, adding further confidence in the analysis. Using data from countries with higher TB burdens, its findings provide populationrepresentative confirmation for prior systematic reviews of studies conducted largely in selected sub-populations from higher income countries. 1, 2 We interpret the association between a self-reported diabetes diagnosis and TB symptoms as evidence of an association between the biological presence of diabetes and active TB disease. Self-report can potentially bias this interpretation. 32 In groups unlikely to know their diabetes status, true diabetes prevalence will likely be underestimated. 33 In light of this underreporting, our estimate may be biased toward the null, given that true diabetics who were misclassified as non-diabetics or were excluded from the analysis due to non-response are also likely to be at risk for TB. Self-reported TB symptoms also have less than perfect sensitivity and specificity compared with gold-standard diagnostics. Of particular concern is that TB symptoms may be non-specific since pneumonia and bronchitis can cause hemoptysis of substantial duration, as previously reported. 34, 35 Thus, the estimated relationship may also partly represent the 
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relationship between diabetes and other respiratory ailments. If diabetes were also positively associated with these other respiratory ailments, the relationship we estimated would be biased away from the null. Unfortunately, we know of no populationrepresentative data sets including laboratory tests for TB and diabetes. Of some reassurance, our estimates are strikingly consistent with non-populationrepresentative studies employing gold standard diagnostics. 1, 2 It is possible that individuals who develop complications of diabetes severe enough to seek more frequent medical care are more likely to be diagnosed with TB-leading to an observed association between TB and diabetes, though tuberculosis may have preceded diabetes. In our analysis, this possibility is unlikely because symptoms of TB were self-reported (i.e. blood in cough and cough lasting 53 weeks) as occurring in the past year, while diabetes diagnosis could have occurred at any time in the person's life. Furthermore, for many people, the timescale of TB infection to symptoms is shorter than the timescale from the development of diabetes to the experience of symptoms that they themselves notice.
To the extent that the risks of both TB and T2DM are increased by HIV/AIDS, increases in HIV/AIDS could account for some of the association we have estimated here. It is well accepted that TB resurgence in many countries has been increased by HIV/AIDS. However, a review of the literature 36-42 on the relationship between diabetes and HIV/AIDS finds no studies reporting evidence of a causative increasenotably, Hepatitis C co-infection and the use of highly active anti-retroviral therapy (HAART) particularly when protease inhibitors are included increase the risk of diabetes. In our sample of countries, those with the highest HIV/AIDS prevalence generally had low access to HAART in 2003, and, therefore, we believe that the possibility is small that HIV/AIDS explains the TB/diabetes relationships that we have observed.
In our country-level analysis, we interpret the longitudinal increase in TB prevalence associated with diabetes prevalence as evidence suggestive of a causal relationship between diabetes and TB manifesting at the population health level. Differential changes in country health-care systems leading to increased diagnosis of both diabetes and TB could also produce this result; a possibility we cannot exclude. However, we note that most developing countries between the 1990s and early 2000s did not drastically expand their diabetes screening, diagnostic or management services. Also, in our country-level analyses, we adjusted for country-fixed effects and per-capita GDP levels as proxies for the types of care provided by health systems. Additionally, in the individual-level analysis, even after adjusting for health insurance status and per-capita income, individuals with diagnosed diabetes were more likely to report symptoms of TB.
While the sample size in the study is large, a substantial number of individuals are excluded in the multivariable analysis because of non-response to survey items. Those not providing complete responses tended to be poorer and have less education, though reassuringly, in univariable analyses, the association between TB and the covariates were similar for the restricted study sample and all individuals providing responses to a given item. The mechanisms by which diabetes increases TB risk at the individual and population levels remain to be elucidated. Our individual-level analysis is crosssectional and cannot distinguish the temporal ordering of diabetes onset, TB infection and TB symptom onset. Country-level analyses do not capture patterns of population mixing or other risk factors contributing to the observed associations. While the country-and individual-level relationships we estimate are broadly consistent, we do not observe even stronger associations of TB and diabetes in socioeconomic subpopulations where these two diseases are most likely to mix. However, if failure to be diagnosed with diabetes were associated with relative poverty, then differential under-diagnosis could explain our failure to detect an economic gradient.
Future research priorities include epidemiologic and modeling studies. Prospective cohort studies employing biochemical tests to definitively detect TB and diabetes at multiple time points can address the time ordering of diabetes onset and TB infection or reactivation. Such studies can also link individual and population risks including the interactions of risk factors and interplay of social determinants. Policy analyses using computer-based population models translate TB/diabetes associations and trends in prevalence into projections of future burdens. Such models can also assess the relative value of strategies including accelerating the availability of diabetes interventions and combining or targeting diabetes and TB initiatives. 11, 43 Interventions reducing diabetes could potentially reduce individual-level risks of TB and indirectly avert increases in TB population prevalence.
An increase in the individual risk of TB associated with T2DM has important public health implications. At a national level, the seriousness of this risk depends crucially on the current and future levels and distributions of TB, diabetes and their risk factors throughout the population. Proactive evidence-based prevention policies are crucial for countries facing large TB/diabetes burdens.
Supplementary data
Supplementary data are available at IJE online.
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KEY MESSAGES
In lower income countries, symptoms of TB are more likely to occur in individuals reporting a past diabetes diagnosis.
Countries with higher diabetes prevalence were more likely to see increases in TB between the mid-1990s and early 2000s.
Of particular concern, populous countries including India, Peru and the Russia Federation, which have relatively large TB burdens, have seen rapid increases in their diabetes prevalence.
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In his classic 1971 paper, Abdel Omran put forward the theory of The Epidemiologic Transition, positing that societies experience three principal stages of disease status: beginning with an Age of Pestilence and Famine, followed by an Age of Receding Pandemics and finally an Age of Degenerative Disease. 1 Although exceptions to Omran's theory exist, 2-4 the concept remains relevant to contextualize major shifts in epidemic dynamics. The recently observed co-occurrence of tuberculosis (TB) and diabetes mellitus (DM) pandemics, however, represents a new phenomenon in the classic epidemiological transition, a consequence of rapidly growing non-communicable diseases (i.e. DM)-a result of transitioning lifestyles towards greater intake of calories and lower physical activity-coupled with an inability to reduce the global burden of TB. The shifting epidemiology, sociology and clinical care of the concurrent DM-TB disease state, like the combination of other infectious and chronic diseases, will influence public health agendas and challenge the classical silos of communicable vs non-communicable diseases. This situation, however, may also offer major opportunities for research and for rethinking health systems' orientation and structure.
Omran accurately predicted that societal improvements in economic, social, cultural and political capacities would affect epidemic transitions, but he did not foresee that elements of globalization and economic development could so quickly bring about an Age of Degenerative Diseases before the Age of Receding Pandemics was curtailed. The increasing co-occurrence of TB and DM is a clear case in point, especially in countries with rapidly emerging economies such as India and China, resulting in a confluence of two pandemics-one communicable and another non-communicable. In this issue of the IJE, Goldhaber-Fiebert et al. 5 report an association between DM and TB from a population-based survey of low-and middle-income countries (LMIC) that is consistent with findings from previous research. [6] [7] [8] DM has been recognized as a risk factor for TB for decades, but although the link between DM and TB is not new, only with the recent explosive DM pandemic has the importance of understanding the relationships between DM and TB emerged as a global health priority. 7, 9 TB causes enormous morbidity and mortality globally; annually, 49 million people develop active TB and nearly 2 million die due to TB-now the second leading cause of death from an
